Anbio Biotechnology (NNNN) vs Jin Medical International Ltd. (ZJYL)

Anbio Biotechnology and Jin Medical International Ltd. are both Medical Instruments & Supplies companies. Anbio Biotechnology is the larger, with a market value of $474.8M against $340.9M — 1.4× the size. Across the 4 metrics below, Anbio Biotechnology leads on 3 and Jin Medical International Ltd. on 1.

Valuation

Metric NNNN ZJYL Medical Instruments & Supplies median
P/E — — 33.75
P/S — n/m 2.52
P/B n/m n/m 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m n/m 14.62
EV/Sales n/m n/m 2.88
Earnings yield — — (2.67%)
Free cash flow yield 0.00% 0.00% 0.09%

Profitability

Metric NNNN ZJYL Medical Instruments & Supplies median
Gross margin — — 54.29%
Operating margin — — 1.07%
Net margin — — (1.61%)
Free cash flow margin 0.00% 0.00% 1.08%
Return on equity 0.00% 0.00% (1.32%)
Return on assets 0.00% 0.00% 0.00%
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NNNN ZJYL Medical Instruments & Supplies median
Revenue growth (TTM) — — 8.85%
EPS growth (last fiscal year) 150.00% (55.88%) 8.65%
Revenue growth, 5-year CAGR — (0.07%) 9.17%
Net income growth, 5-year CAGR — (15.14%) 0.00%

Health

Metric NNNN ZJYL Medical Instruments & Supplies median
Debt to equity 0.00 0.10 0.10
Current ratio 344.45 1.95 2.48
Net debt to EBITDA (2.06) (34.79) 0.89

Dividend

Metric NNNN ZJYL Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric NNNN ZJYL Medical Instruments & Supplies median
Market cap 474.84m 340.91m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack